Searched for
COVIDSHIELD
Centre should urgently address alleged side-effects of Covishield, says Delhi health ministerUK-headquartered pharmaceutical giant AstraZeneca has admitted that in "very rare cases", its COVID-19 vaccine can cause a blood clot-relat...- AstraZeneca acknowledges its covid vaccine, Covishield, can lead to rare blood clot side effects; Here's what we knowCovishield Covid Vaccine: The Covishield COVID-19 vaccine, developed by AstraZeneca in partnership with the University of Oxford, has been ...
- What you need to know about getting Bharat Biotech's nasal vaccine iNCOVACCBharat Biotech has recently introduced its intranasal Covid vaccine, which will be given as a booster dose, as concerns about the Covid BF....
- Bharat Biotech’s Covid-19 nasal vaccination now available on CoWIN app; Know how can you get itA heterologous booster dose of the nasal vaccination can be given to those who have already received Covishield and Covaxin.
- CCI clears Serum Institute Life Sciences-Biocon Biologics dealOnce the deal is complete, Serum Institute Life Sciences Pvt Ltd will have about 15 per cent stake in Biocon Biologics Ltd, according to th...
- Vaccine not mandatory; 2,116 adverse events, deaths after immunisation, Centre tells SCThe Health Ministry said that all clinical data that could be shared have been placed in public domain and it was not possible to share any...
- 48 Delta Plus cases found so far, Maharashtra tops the listInfections with the Delta Plus variant have been reported from Madhya Pradesh, Maharashtra, Punjab, Gujarat, Kerala, Andhra Pradesh, Tamil ...
- Bharti Realty to vaccinate employees by June 15The Bharti Realty has partnered with Apollo Hospitals, Government Health Services and other medical service providers and will be administe...
- Kerala CM attacks Centre’s vaccine policy, to buy 1 crore vaccine to provide free to 18-44 year age groupThe Kerala government on Wednesday decided to procure one crore doses of COVID-19 vaccine for the third phase of the vaccination drive from...
- Health Ministry releases data on coronavirus vaccine availabilityThe health ministry said there was ‘fear mongering’ about availability, refuting claims by some states that they were not getting enough su...
- Maharashtra government alleges discrimination in vaccine supplyMaharashtra health minister Rajesh Tope on Thursday said that Maharashtra in spite of having more Covid cases was getting fewer vaccines.
- Vaccine drive gains momentum in Delhi as hesitancy easesMany hospitals saw a big turnout and even reached their daily target by 2pm. Many said the apprehension to get vaccinated is slowly fading ...
- India's Covid-19 vaccination drive starts successfully even as doubts remain over CovaxinAuthorities have given emergency-use approval for two jabs -- "Covishield", a version of the Oxford-AstraZeneca vaccine, and the Indian-mad...
- First consignment of Covishield vaccine arrives in BengaluruThe health department officials received the consignment which was then transported to the government cold storage facility in the health o...
- Covid: How states are gearing for world's largest vaccination programWest Bengal has identified 6 lakh health workers were identified, and 20,000 vaccination centres for the purpose. Chhattisgarh even claimed...
- Covishield and Covaxin: All you need to know about the DCGI-approved vaccinesET rounds up facts and some questions on Covishield and Covaxin, approved by DCGI on Sunday
- India may authorise some COVID-19 vaccines in weeks, says health secretarySix vaccines, including Astra Zeneca's Covidshield and Bharat Biotech's Covaxin, are in trial stages, Federal health secretary Rajesh Bhush...
- Serum Institute rejects charges levelled by vaccine trial participant, will seek Rs 100 crore in damagesA 40-year-old man who took part in the 'Covidshield' vaccine trial in Chennai has alleged serious side effects, including a virtual neurolo...
- Centre may purchase 300-400 million Covishield doses by July 2021: Adar PoonawallaSII has partnered with global pharma giant AstraZeneca and Oxford University for the vaccine candidate 'Covidshield'. "As of now we don't h...
- Serum Institute of India seeks DCGI permission for phase 2/3 clinical trials of Oxford's COVID 'vaccine'The sources told that the Pune-based drug firm submitted its application to the DCGI on Friday seeking permission for conducting the trials...
Load More
